USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark SALICINIUM was filed as Word mark on 08/09/2010 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 04/10/2012.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Word mark |
| File reference | 85102816 |
| Register number | 4123876 |
| Application date | August 9, 2010 |
| Publication date | January 24, 2012 |
| Entry date | April 10, 2012 |
Trademark owner
218 Main Street
98033 Kirkland
US
98033 Kirkland
US
Trademark representatives
goods and services
5
Drug preparations, liquid drug formulations, prescription and non-prescription medications, namely, capsules, tablets, powders, and pharmaceutical preparations, injectable pharmaceuticals, topical formulations and patches, infusion pharmaceutical preparations, intravenous pharmaceutical formulations, and pharmaceutical solutions for medical and nutritional purposes and uses, namely, for treatment of immune disorders, immune deficiencies, cellular proliferative disorders, namely, cancer, bacterial, viral and fungal infections, physiological pH imbalances, digestive disorders, and nutritional and dietary deficiencies; Drugs and medications namely, anti-inflammatories, pharmaceutical preparations used in cancer therapeutics, antiseptics, antibiotics, antivirals, antifungal preparations, antimicrobial preservatives for cosmetics and pharmaceuticals, pharmaceutical preparations for the treatment of immune system related diseases and disorders, immune supplemental, nutritional supplements for stimulating the immunity system, pharmaceutical preparations for wound healing, nutritional supplements for balancing immune system-related factors, namely, blood sugar and pH levels, nutritional supplements for adjusting and balancing pH levels and other immune system-related factors, and dietary supplements and balancing drugs and medications, namely, medications incorporating active drugs and other therapeutic agents effective for alleviating immune disorders, immune deficiencies, cellular proliferative disorders, physiological pH imbalances, digestive disorders, and nutritional and dietary deficiencies, all for oral, topical, intravenous, injection and infusion therapy
ID: 1385102816